[PDF][PDF] Transneuronal propagation of pathologic α-synuclein from the gut to the brain models Parkinson's disease

…, S Lee, JH Lee, WR Kim, M Kook, CA Foss… - Neuron, 2019 - cell.com
Analysis of human pathology led Braak to postulate that α-synuclein (α-syn) pathology could
spread from the gut to brain via the vagus nerve. Here, we test this postulate by assessing α-…

2-(3-{1-Carboxy-5-[(6-[18F]Fluoro-Pyridine-3-Carbonyl)-Amino]-Pentyl}-Ureido)-Pentanedioic Acid, [18F]DCFPyL, a PSMA-Based PET Imaging Agent for Prostate …

Y Chen, M Pullambhatla, CA Foss, Y Byun… - Clinical cancer …, 2011 - AACR
Purpose: We have synthesized and evaluated in vivo 2-(3-{1-carboxy-5-[(6-[ 18 F]fluoro-pyridine-3-carbonyl)-amino]-pentyl}-ureido)-pentanedioic
acid, [ 18 F]DCFPyL, as a potential …

Preclinical evaluation of novel glutamate-urea-lysine analogues that target prostate-specific membrane antigen as molecular imaging pharmaceuticals for prostate …

…, KP Maresca, FJ Femia, JC Marquis, CA Foss… - Cancer research, 2009 - AACR
Prostate-specific membrane antigen (PSMA) is expressed in normal human prostate epithelium
and is highly up-regulated in prostate cancer. We previously reported a series of novel …

Radiolabeled Small-Molecule Ligands for Prostate-Specific Membrane Antigen: In vivo Imaging in Experimental Models of Prostate Cancer

CA Foss, RC Mease, H Fan, Y Wang, HT Ravert… - Clinical cancer …, 2005 - AACR
Purpose: Prostate-specific membrane antigen (PSMA) is a cell surface protein that is
overexpressed in prostate cancer, including hormone-refractory and metastatic disease. Our goal in …

Synthesis and evaluation of technetium-99m-and rhenium-labeled inhibitors of the prostate-specific membrane antigen (PSMA)

SR Banerjee, CA Foss, M Castanares… - Journal of medicinal …, 2008 - ACS Publications
The prostate-specific membrane antigen (PSMA) is increasingly recognized as a viable target
for imaging and therapy of cancer. We prepared seven 99m Tc/Re-labeled compounds by …

N-[N-[(S)-1,3-Dicarboxypropyl]Carbamoyl]-4-[18F]Fluorobenzyl-l-Cysteine, [18F]DCFBC: A New Imaging Probe for Prostate Cancer

RC Mease, CL Dusich, CA Foss, HT Ravert… - Clinical Cancer …, 2008 - AACR
Purpose: Previously, we showed successful imaging of xenografts that express the prostate-specific
membrane antigen (PSMA) using small-animal positron emission tomography (PET) …

Radiohalogenated prostate-specific membrane antigen (PSMA)-based ureas as imaging agents for prostate cancer

Y Chen, CA Foss, Y Byun, S Nimmagadda… - Journal of medicinal …, 2008 - ACS Publications
To extend our development of new imaging agents targeting the prostate-specific
membrane antigen (PSMA), we have used the versatile intermediate 2-[3-(5-amino-1-carboxy-pentyl)-…

PET imaging in prostate cancer: focus on prostate-specific membrane antigen

RC Mease, CA Foss, MG Pomper - Current topics in medicinal …, 2013 - ingentaconnect.com
Prostate cancer (PCa) is the second leading cause of cancer-related death in American men.
Positron emission tomography/computed tomography (PET/CT) with emerging …

Targeting collagen strands by photo-triggered triple-helix hybridization

Y Li, CA Foss, DD Summerfield… - Proceedings of the …, 2012 - National Acad Sciences
Collagen remodeling is an integral part of tissue development, maintenance, and regeneration,
but excessive remodeling is associated with various pathologic conditions. The ability to …

PET imaging of microglia by targeting macrophage colony-stimulating factor 1 receptor (CSF1R)

AG Horti, R Naik, CA Foss, I Minn… - Proceedings of the …, 2019 - National Acad Sciences
While neuroinflammation is an evolving concept and the cells involved and their functions
are being defined, microglia are understood to be a key cellular mediator of brain injury and …